Geneos Wealth Management’s Archrock AROC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$267K Buy
7,670
+7,270
+1,818% +$232K 0.01% 868
2025
Q4
$10.4K Hold
400
﹤0.01% 1955
2025
Q3
$10.5K Sell
400
-74
-16% -$1.78K ﹤0.01% 1946
2025
Q2
$11.8K Sell
474
-599
-56% -$14.7K ﹤0.01% 2259
2025
Q1
$28.2K Buy
1,073
+1,024
+2,090% +$27.6K ﹤0.01% 2179
2024
Q4
$1.22K Hold
49
﹤0.01% 2728
2024
Q3
$992 Buy
+49
New +$992 ﹤0.01% 2449
2024
Q2
Sell
-50
Closed -$984 2063
2024
Q1
$984 Buy
+50
New +$854 ﹤0.01% 2023
2018
Q3
Sell
-632
Closed -$7K 2407
2018
Q2
$7K Hold
632
﹤0.01% 1814
2018
Q1
$5K Hold
632
﹤0.01% 1835
2017
Q4
$6K Hold
632
﹤0.01% 1762
2017
Q3
$7K Hold
632
﹤0.01% 1663
2017
Q2
$7K Hold
632
﹤0.01% 1623
2017
Q1
$7K Hold
632
﹤0.01% 1588
2016
Q4
$8K Hold
632
﹤0.01% 1490
2016
Q3
$8K Hold
632
﹤0.01% 1426
2016
Q2
$6K Hold
632
﹤0.01% 1449
2016
Q1
$4K Buy
+632
New +$3.51K ﹤0.01% 1524

Other funds holding AROC

Geneos Wealth Management's AROC Position: Q1 2026 in Review

Geneos Wealth Management increased its Archrock (AROC) stake by 1,818% in Q1 2026, buying an estimated $232K and bringing the position to 7,670 shares worth $267K. The position accounts for 0.01% of the portfolio, ranked #868.

Geneos Wealth Management first reported a position in AROC in Q1 2016 and has held it in 18 quarters since. 431 funds tracked by Wall St. Rank hold AROC as of Q1 2026.

  • Geneos Wealth Management held 7,670 shares of Archrock worth $267K as of Q1 2026.
  • Geneos Wealth Management bought 7,270 Archrock shares in Q1 2026, an estimated $232K.
  • Archrock made up 0.01% of Geneos Wealth Management's portfolio in Q1 2026, its #868 holding.
  • Geneos Wealth Management first reported a position in Archrock in Q1 2016 and has held it in 18 quarters since.
  • 431 funds tracked by Wall St. Rank held Archrock as of Q1 2026.

Based on Geneos Wealth Management's 13F filing for Q1 2026, filed 5 May 2026.